Physician profile
Nancy Thong
NPI 1639567597
$531.65
in general payments reported to CMS, 2019-2025
14 companies · $25.68 in 2025
The $25.68 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $338 · 2024: $168 · 2025: $25.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.49 |
| Education | $113.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $79.00 | 2023 | Tremfya |
| Octapharma USA, INC. | $76.41 | 2023-2024 | Cutaquig, Octagam Immune Globulin (Human) |
| Novartis Pharmaceuticals Corporation | $72.53 | 2023-2024 | |
| Abbvie INC. | $51.49 | 2023-2024 | |
| Ucb, INC. | $35.62 | 2023-2024 | Cimzia |
| Celltrion USA INC. | $34.16 | 2023 | Yuflyma |
| Mallinckrodt Hospital Products INC. | $32.99 | 2023 | Acthar |
| Astrazeneca Pharmaceuticals LP | $29.88 | 2024 | |
| Fresenius Kabi USA, LLC | $25.68 | 2025 | |
| Amgen INC. | $21.63 | 2024 | Tavneos |
| Ani Pharmaceuticals, INC. | $20.91 | 2023 | Purified Cortrophin Gel |
| Pfizer INC. | $19.62 | 2024 | |
| Alexion Pharmaceuticals, INC. | $17.63 | 2023 | Strensiq |
| Glaxosmithkline, LLC. | $14.10 | 2023 | Benlysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Thong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.